Prosecution Insights
Last updated: May 29, 2026
Application No. 18/339,644

CURABLE COMPOSITION

Non-Final OA §103
Filed
Jun 22, 2023
Priority
Jul 27, 2022 — JP 2022-119432
Examiner
ROSWELL, JESSICA MARIE
Art Unit
1767
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Tokyo Ohka Kogyo Co., Ltd.
OA Round
1 (Non-Final)
52%
Grant Probability
Moderate
1-2
OA Rounds
6m
Est. Remaining
89%
With Interview

Examiner Intelligence

Grants 52% of resolved cases
52%
Career Allowance Rate
404 granted / 775 resolved
-12.9% vs TC avg
Strong +36% interview lift
Without
With
+36.5%
Interview Lift
resolved cases with interview
Typical timeline
3y 6m
Avg Prosecution
35 currently pending
Career history
830
Total Applications
across all art units

Statute-Specific Performance

§101
0.3%
-39.7% vs TC avg
§103
74.7%
+34.7% vs TC avg
§102
5.5%
-34.5% vs TC avg
§112
3.1%
-36.9% vs TC avg
Black line = Tech Center average estimate • Based on career data from 775 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention. Claim(s) 1 and 3-9 is/are rejected under 35 U.S.C. 103 as being unpatentable over Shimohara et al. (US Serial No. 2008/0241485), in view of Bollen (EP 3287499) and Seno et al. (US Serial No. 2012/0242768). Regarding claims 1, 4, and 5; Shimohara et al. teaches an inkjet recording composition comprising a vinyl ether monomer [0077, 0086], a compound having 3-10 mercaptan groups [0130], an onium salt photoacid generator [0205], and a photoradical generating agent [0020-0021; clms8-9]. Shimohara et al. fails to teach a stabilizing agent comprising an imidazole compound. Bollen teaches a composition suitable for use as inkjet ink, the composition further comprising a dispersion-stabilizing compound such as an imidazole having a thiol group (radical polymerizable group) [0109]. Shimohara et al. and Bollen are analogous art because they are both concerned with the same field of endeavor, namely photopolymerizable inkjet ink compositions. At the time of filing, a person of ordinary skill in the art would have found it obvious to add the imidazole dispersion stabilizer, as taught by Bollen, to the composition of Shimohara et al., and would have been motivated to do so in order to achieve dispersion stability of the ink composition, as suggested by Bollen [0108]. Shimohara et al. teaches thioxanthone [0206], however fails to teach a photosensitizing agent comprising N-alkyl carbazole. Seno et al. teaches a photocurable inkjet ink composition comprising photosensitizers such as N-vinyl carbazole and thioxanthone [0111]. Therefore, Seno et al. teaches that N-vinyl carbazole and thioxanthone are functional equivalents for the purpose of functioning as a photosensitizer for inkjet ink compositions. It is prima facie obvious to substitute art-recognized functional equivalents known for the same purpose (See MPEP § 2144.06). Regarding claim 3; Shimohara et al. teaches the solvent is optional [0164]. Regarding claim 6; Shimohara et al. does not explicitly teach an absolute difference between an initial viscosity and post storage viscosity. In view of the compositions being substantially similar, the compositions would necessarily possess the same properties. Since the PTO does not have proper means to conduct experiments, the burden of proof is now shifted to the applicants to show otherwise. See In re Best, 562 F.2d 1252, 195 USPQ 430 (CCPA 2977) and In re Fitzgerald, 205 USPQ 594 (CCPA). Regarding claim 7; Shimohara et al. teaches a cured film [0148]. Regarding claims 8-9; Shimohara et al. teaches a method of coating via inkjet, exposing the coating to irradiation, and heating said coating [0004, 0248-0251]. Claim(s) 2 is/are rejected under 35 U.S.C. 103 as being unpatentable over Shimohara et al. (US Serial No. 2008/0241485), in view of Bollen (EP 3287499) and Seno et al. (US Serial No. 2012/0242768), as applied to claim 1 above, and further in view of Ide et al. (US Serial No. 2011/0001190). Shimohara et al., Bollen, and Seno et al. render obvious the basic claimed curable composition, as set forth above, with respect to claim 1. Regarding claim 2; Shimohara et al. fails to teach the photoacid generator comprises a diazomethane compound. Ide et al. teaches a photocurable thiol-ene type inkjet ink composition comprising a photoacid generator such as a diazomethane [0191]. Shimohara et al. and Ide et al. are analogous art because they are both concerned with the same field of endeavor, namely photocurable inkjet ink compositions. At the time of filing, a person of ordinary skill in the art would have found it obvious to add the diazomethane photoacid generator, as taught by Ide et al., to the composition of Shimohara et al., and would have been motivated to do so in order to achieve quick and efficient polymerization of the compound. Correspondence Any inquiry concerning this communication or earlier communications from the examiner should be directed to JESSICA ROSWELL whose telephone number is (571)270-5453. The examiner can normally be reached M-F 8:00 am to 5:00 pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Mark Eashoo can be reached at 571-272-1197. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /JESSICA M ROSWELL/ Primary Examiner, Art Unit 1767
Read full office action

Prosecution Timeline

Jun 22, 2023
Application Filed
Apr 14, 2026
Non-Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12630747
ULTRAVIOLET CURABLE SILICONE ADHESIVE COMPOSITION AND CURED PRODUCT OF SAME
4y 11m to grant Granted May 19, 2026
Patent 12630745
RADIATION CURABLE PRIMER ADHESIVE
4y 7m to grant Granted May 19, 2026
Patent 12630470
Polyamideimide Film and Window Cover Film Including the Same
4y 6m to grant Granted May 19, 2026
Patent 12630727
PHOTOCURABLE INKJET PRINTING INK COMPOSITION
3y 8m to grant Granted May 19, 2026
Patent 12624167
CURABLE COMPOSITIONS CONTAINING THIOL COMPOUNDS
6y 0m to grant Granted May 12, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
52%
Grant Probability
89%
With Interview (+36.5%)
3y 6m (~6m remaining)
Median Time to Grant
Low
PTA Risk
Based on 775 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month